PLAT and Stroke: The controversy about the efficacy of tPA in acute IS patients older than 80 years of age was evaluated by the International Stroke Trial III (IST-III) [16] in 3035 patients and concluded that in patients older than 80 years of age, IV-tPA was as efficacious as in patients less than 80 years of age.